• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻找新的耳霉菌种及其对不同抗真菌药物的敏感性。

A search for new otomycotic species and their sensitivity to different antifungals.

作者信息

Ahmed Mohammed Rifaat, Abou-Halawa Ashraf Saad, Hessam Waheed F, Abdelkader Diaa' Salaheldin Aly

机构信息

Faculty of Medicine, Department of Otolaryngology, Suez Canal University, Ismailia, Egypt.

Faculty of Medicine, Department of Microbiology and Immunology, Suez Canal University, Ismailia, Egypt.

出版信息

Interv Med Appl Sci. 2018 Sep;10(3):145-149. doi: 10.1556/1646.10.2018.28.

DOI:10.1556/1646.10.2018.28
PMID:30713753
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6343575/
Abstract

BACKGROUND

Otomycosis is a common ear problem in countries with hot and humid climate. Emergence of new fungal species is a possibility particularly in patients with chronic illness or who receives antibiotics either systemically or topically.

AIM

To identify the otomycotic species, which are responsible for developing the otomycosis.

METHODS

A descriptive study was carried out in 63 patients who were clinically diagnosed with otomycosis. Swabs were taken from the fungal debris to identify the causative agent and to determine the effective antifungals against it.

RESULTS

species were the most common agents and were found in 47 patients (74.6%), represented by (36.5%), (27%), (6.5%), and (4.8%). Ketoconazole (90%) and miconazole (76%) were the most effective antifungals against the species obtained from cultures, whereas fluconazole was the least effective.

CONCLUSIONS

Although there is no change in the mycology of otomycosis, there is still a significant variability in the isolated species and in their sensitivity to antifungal drugs. Ketoconazole exhibited broad spectrum effect against fungal isolates in this study, whereas fluconazole was the least efficacious.

摘要

背景

在气候炎热潮湿的国家,耳真菌病是一种常见的耳部疾病。新真菌种类的出现是有可能的,特别是在患有慢性病或全身或局部使用抗生素的患者中。

目的

鉴定导致耳真菌病的耳真菌种类。

方法

对63例临床诊断为耳真菌病的患者进行了描述性研究。从真菌残渣中采集拭子,以鉴定病原体并确定针对其有效的抗真菌药物。

结果

是最常见的病原体,在47例患者(74.6%)中发现,其中 占(36.5%), 占(27%), 占(6.5%), 占(4.8%)。酮康唑(90%)和咪康唑(76%)是对培养获得的菌种最有效的抗真菌药物,而氟康唑效果最差。

结论

虽然耳真菌病的真菌学没有变化,但分离出的菌种及其对抗真菌药物的敏感性仍存在显著差异。在本研究中,酮康唑对真菌分离株表现出广谱作用,而氟康唑效果最差。

相似文献

1
A search for new otomycotic species and their sensitivity to different antifungals.寻找新的耳霉菌种及其对不同抗真菌药物的敏感性。
Interv Med Appl Sci. 2018 Sep;10(3):145-149. doi: 10.1556/1646.10.2018.28.
2
Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran.伊朗阿瓦士耳霉菌病病原体的抗真菌药敏谱
Curr Med Mycol. 2020 Jun;6(2):18-22. doi: 10.18502/CMM.6.2.2696.
3
In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis.体外联合特比萘芬与酮康唑治疗体外分离的高特比萘芬 MIC 值烟曲霉菌属致外耳道真菌病。
Mycopathologia. 2023 Apr;188(1-2):119-127. doi: 10.1007/s11046-022-00698-7. Epub 2022 Nov 30.
4
In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens.氟康唑、伊曲康唑和伏立康唑对耳真菌病原体的体外活性。
J Laryngol Otol. 2009 Sep;123(9):978-81. doi: 10.1017/S0022215109005489. Epub 2009 May 20.
5
Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.从中国西部耳真菌病患者中分离出的曲霉菌的分子鉴定及体外抗真菌药敏试验。
Mycopathologia. 2020 Jun;185(3):527-535. doi: 10.1007/s11046-020-00448-7. Epub 2020 Apr 28.
6
Identification of Fungal Pathogens in Otomycosis and Their Drug Sensitivity: Our Experience.耳真菌病中真菌病原体的鉴定及其药敏情况:我们的经验
Int Arch Otorhinolaryngol. 2018 Oct;22(4):400-403. doi: 10.1055/s-0038-1626702. Epub 2018 Apr 12.
7
Lamisil, a potent alternative antifungal drug for otomycosis.兰美抒,一种用于治疗耳霉菌病的强效抗真菌替代药物。
Curr Med Mycol. 2015 Mar;1(1):18-21. doi: 10.18869/acadpub.cmm.1.1.18.
8
Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran.从伊朗耳真菌病病例中分离的黑曲霉的种属鉴定和抗真菌药敏试验。
Mycoses. 2012 Jul;55(4):333-8. doi: 10.1111/j.1439-0507.2011.02103.x. Epub 2011 Sep 7.
9
Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents.伊朗北部的耳真菌病:常见病原体和抗真菌药物耐药性。
Eur Arch Otorhinolaryngol. 2014 May;271(5):953-7. doi: 10.1007/s00405-013-2486-0. Epub 2013 Apr 18.
10
Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients.从耳真菌病患者中分离的曲霉属 Nigri 节段菌株的种属鉴定和体外抗真菌药敏试验。
J Mycol Med. 2018 Jun;28(2):279-284. doi: 10.1016/j.mycmed.2018.02.003. Epub 2018 Mar 11.

引用本文的文献

1
Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.从耳真菌病患者中分离出的酵母和霉菌的分子鉴定及抗真菌药敏试验。
Mycopathologia. 2021 May;186(2):245-257. doi: 10.1007/s11046-021-00537-1. Epub 2021 Mar 15.
2
Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran.伊朗阿瓦士耳霉菌病病原体的抗真菌药敏谱
Curr Med Mycol. 2020 Jun;6(2):18-22. doi: 10.18502/CMM.6.2.2696.

本文引用的文献

1
Epidemiology, causative agents, and risk factors affecting human otomycosis infections.影响人类耳真菌病感染的流行病学、病原体和危险因素。
Turk J Med Sci. 2015;45(4):820-6. doi: 10.3906/sag-1407-17.
2
Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification.印度次大陆的原发性耳真菌病:诱发因素、微生物学及分类
Int J Microbiol. 2014;2014:636493. doi: 10.1155/2014/636493. Epub 2014 May 18.
3
Otomycosis; clinical features, predisposing factors and treatment implications.耳真菌病;临床特征、易患因素和治疗意义。
Pak J Med Sci. 2014 May;30(3):564-7. doi: 10.12669/pjms.303.4106.
4
Prevalence of otomycosis in Khouzestan Province, south-west Iran.伊朗西南部胡齐斯坦省耳真菌病的患病率
J Laryngol Otol. 2013 Jan;127(1):25-7. doi: 10.1017/S0022215112002277. Epub 2012 Nov 20.
5
Otomycosis in Shanghai: aetiology, clinical features and therapy.上海地区的耳真菌病:病因、临床特征和治疗。
Mycoses. 2012 Sep;55(5):404-9. doi: 10.1111/j.1439-0507.2011.02132.x. Epub 2011 Oct 17.
6
Ototopical antifungals and otomycosis: a review.耳用抗真菌药与耳霉菌病:综述
Int J Pediatr Otorhinolaryngol. 2008 Apr;72(4):453-9. doi: 10.1016/j.ijporl.2007.12.005. Epub 2008 Feb 14.
7
Otomycosis in western Nigeria.尼日利亚西部的耳霉菌病
Mycoses. 2008 Jan;51(1):67-70. doi: 10.1111/j.1439-0507.2007.01441.x.
8
Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal.尼泊尔加德满都特里布万大学教学医院耳鼻喉科门诊的耳真菌病患病率。
Ann Otol Rhinol Laryngol. 2003 Apr;112(4):384-7. doi: 10.1177/000348940311200416.
9
Otomycosis in Turkey: predisposing factors, aetiology and therapy.土耳其的耳真菌病:诱发因素、病因及治疗
J Laryngol Otol. 2003 Jan;117(1):39-42. doi: 10.1258/002221503321046621.
10
Concomitant otomycosis and dermatomycoses: a clinical and microbiological study.外耳道真菌病与皮肤真菌病并存:一项临床与微生物学研究。
Eur Arch Otorhinolaryngol. 2003 Jan;260(1):24-7. doi: 10.1007/s00405-002-0514-6. Epub 2002 Aug 1.